Media

Hershey, PA, & Rockville, MD – March 9, 2015 – Immunomic Therapeutics, Inc., (“ITI”) a privately-held biotechnology company developing vaccines based on its proprietary LAMP technology, today announces it will

HERSHEY, PA & ROCKVILLE, MD (PRWEB) FEBRUARY 10, 2015 Immunomic Therapeutics, Inc. (ITI) announced today that Timothy Coleman Ph.D. has joined the company to further develop a comprehensive growth plan and

HERSHEY, Pa., Rockville, Md. and TOKYO, Jan. 29, 2015 /PRNewswire/ -- Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. ("Astellas") today announced they have entered into

HERSHEY, PA AND SAN FRANCISCO, CA (PRWEB) JANUARY 09, 2015 Immunomic Therapeutics, Inc., (ITI), a pioneering vaccine company, announced today that Dr. William Hearl, the Company’s President and CEO, will be

HERSHEY, PA & ROCKVILLE, MD (PRWEB) OCTOBER 28, 2014 Immunomic Therapeutics, Inc.(ITI), a vaccine pioneer in the biotechnology industry, today announced the successful completion of a $6.8 million Series A preferred

The Next Generation of DNA Vaccines Is Poised to Transform the Healthcare Landscape By Teri Heiland October 13, 2014 | Contributed Commentary | Over the last several decades, the advent of biotechnology has